KETAVET VETERINARY

国: イスラエル

言語: 英語

ソース: Ministry of Health

有効成分:

KETAMINE AS HYDROCHLORIDE

から入手可能:

ZOETIS ISRAEL HOLDING B.V., ISRAEL

医薬品形態:

SOLUTION FOR INJECTION

構図:

KETAMINE AS HYDROCHLORIDE 100 MG/ML

投与経路:

I.M, I.V

処方タイプ:

Required

製:

ZOETIS MANUFACTURING & RESEARCH SPAIN, S.L

適応症:

The product may be used to induce anaesthesia:a) in conjunction with butorphanol and medetomidine in the dog and the cat.b) in conjunction with xylazine in the dog and the cat.Based on the benefit/risk assessment performed by the veterinarian the product may be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required in the domestic cat.

承認日:

2022-10-31

製品の特徴

Ketavet Veterinary LPD CC 09.2022
Page 1 of 10
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Ketavet Veterinary
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Ketamine:
100 mg
(Equivalent to ketamine hydrochloride)
115.36 mg
EXCIPIENT(S):
Benzethonium chloride:
0.10 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear, colourless solution, free from visible evidence of
contamination.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs, cats
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product may be used to induce anaesthesia:
a)
in conjunction with butorphanol and medetomidine in the dog and the
cat.
b)
in conjunction with xylazine in the dog and the cat. Based on the
benefit/risk
assessment performed by the veterinarian the product may be used as a
sole agent
for restraint and minor surgical procedures where muscle relaxation is
not required in
the domestic cat.
4.3
CONTRAINDICATIONS
Do not use in animals with pre-existing hepatic or renal pathology.
Do not use in animals with severe cardiac de-compensation, or with
apparent high
blood pressure or glaucoma.
Do not reverse ketamine combinations in dogs with atipamezole.
Do not use ketamine as a sole agent in dogs.
Do not use in animals with eclampsia or pre-eclampsia.
Do not use for surgical intervention on pharynx, larynx, trachea or
bronchial tree, if
sufficient relaxation is not ensured by administration of a muscle
relaxant (intubation
obligatory).
Do not use in cases of known hypersensitivity to the active substance
or any of the
excipients.
Ketavet Veterinary LPD CC 09.2022
Page 2 of 10
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
For very painful and major surgical interventions, as well as for
maintenance of
anaesthesia, a combination with injectable or inhalation anaesthetics
is necessary.
For surgical and diagnostic procedures requiring muscle relaxation,
the concomitant
use of muscle-relaxants is necessary.
For improvement of